BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25871469)

  • 1. Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma.
    Shah VI; McCluggage WG
    Am J Surg Pathol; 2015 May; 39(5):722-4. PubMed ID: 25871469
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
    Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.
    Kruse AJ; Croce S; Kruitwagen RF; Riedl RG; Slangen BF; Van Gorp T; Van de Vijver KK
    Int J Gynecol Cancer; 2014 Nov; 24(9):1616-22. PubMed ID: 25244606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
    Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
    Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
    Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.
    Lee CH; Hoang LN; Yip S; Reyes C; Marino-Enriquez A; Eilers G; Tao D; Chiang S; Fletcher JA; Soslow RA; Nucci MR; Oliva E
    Mod Pathol; 2014 May; 27(5):751-7. PubMed ID: 24186140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of
    Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
    Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel EPC1 gene fusions in endometrial stromal sarcoma.
    Dickson BC; Lum A; Swanson D; Bernardini MQ; Colgan TJ; Shaw PA; Yip S; Lee CH
    Genes Chromosomes Cancer; 2018 Nov; 57(11):598-603. PubMed ID: 30144186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 and p16INK4 positive endometrial stromal sarcoma: a case report with new insights.
    Rekhi B; Motghare P
    Indian J Pathol Microbiol; 2014; 57(4):606-8. PubMed ID: 25308017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
    Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
    Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.
    Hoang L; Chiang S; Lee CH
    Pathology; 2018 Feb; 50(2):162-177. PubMed ID: 29275929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
    Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
    Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial stromal sarcoma--the new genetic paradigm.
    Lee CH; Nucci MR
    Histopathology; 2015 Jul; 67(1):1-19. PubMed ID: 25355621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Values of JAZF1 gene rearrangement detected by fluorescence in-situ hybridization in diagnosis of endometrial stromal tumours].
    Bai QM; Chang B; Tu XY; Bi R; Cheng YF; Huang D; Zhu XL; Wu LJ; Zhang X; Zhou XY; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):769-774. PubMed ID: 29136690
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
    Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
    Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
    Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
    Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian high-grade endometrioid stromal sarcoma with YWHAE and NUTM2B rearrangements.
    Kikuchi N; Sugita S; Nakanishi K; Sugawara T; Segawa K; Ito Y; Kubo T; Fujita H; Hirano H; Tanaka R; Saito T; Hasegawa T
    Pathol Int; 2017 Jun; 67(6):327-329. PubMed ID: 28508463
    [No Abstract]   [Full Text] [Related]  

  • 19. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.
    Kommoss FKF; Mar LM; Howitt BE; Hanley K; Turashvilli G; Buslei R; Irving JA; Dickson BC; Koelsche C; Sinn HP; Schirmacher P; von Deimling A; Chiang S; McCluggage WG; Croce S; Stewart CJR; Lee CH
    Mod Pathol; 2023 Mar; 36(3):100044. PubMed ID: 36788095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.